과제정보
This study was supported by the Korean Society of Gastrointestinal Cancer Research (2021). The funding source did not play any role in the planning or implementation of this study, interpreting the results, or writing the manuscript. The views and opinions expressed are those of the authors and do not necessarily reflect those of the supporting institutions.
참고문헌
- Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 2018;68:471-487. https://doi.org/10.3322/caac.21493
- Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017;3:1335-1342. https://doi.org/10.1001/jamaoncol.2017.0589
- Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol 2020;12:791-807. https://doi.org/10.4251/wjgo.v12.i8.791
- Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-3072. https://doi.org/10.1200/JCO.2007.15.4377
- Rossi RE, Massironi S. The increasing incidence of neuroendocrine neoplasms worldwide: current knowledge and open issues. J Clin Med 2022;11:3794. https://doi.org/10.3390/jcm11133794
- Park MI. Endoscopic treatment for early foregut neuroendocrine tumors. Clin Endosc 2013;46:450-455. https://doi.org/10.5946/ce.2013.46.5.450
- Kwon YH, Jeon SW, Kim GH, et al. Long-term follow up of endoscopic resection for type 3 gastric NET. World J Gastroenterol 2013;19:8703-8708. https://doi.org/10.3748/wjg.v19.i46.8703
- Kim GH, Kim JI, Jeon SW, et al. Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol 2014;29:318-324. https://doi.org/10.1111/jgh.12390
- Rossi RE, Rausa E, Cavalcoli F, Conte D, Massironi S. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity. Scand J Gastroenterol 2018;53:835-842. https://doi.org/10.1080/00365521.2018.1468479
- Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer 2008;123:867-873. https://doi.org/10.1002/ijc.23529
- Santos AP, Santos AC, Castro C, et al. Visceral obesity and metabolic syndrome are associated with well-differentiated gastroenteropancreatic neuroendocrine tumors. Cancers (Basel) 2018;10:293. https://doi.org/10.3390/cancers10090293
- Katz LH, Levi Z, Twig G, et al. Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents. Int J Cancer 2018;143:1876-1883. https://doi.org/10.1002/ijc.31589
- Soto-Solis R, Romano-Munive AF, Santana de Anda K, Barreto-Zuniga R. Factors related to gastric neuroendocrine tumors. Rev Gastroenterol Mex (Engl Ed) 2019;84:52-56. https://doi.org/10.1016/j.rgmxen.2018.06.007
- Campana D, Ravizza D, Ferolla P, et al. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study. Endocrine 2017;56:633-638. https://doi.org/10.1007/s12020-016-1099-y
- Massironi S, Campana D, Partelli S, et al. Heterogeneity of duodenal neuroendocrine tumors: an Italian multicenter experience. Ann Surg Oncol 2018;25:3200-3206. https://doi.org/10.1245/s10434-018-6673-5
- Rossi RE, Milanetto AC, Andreasi V, et al. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy. J Endocrinol Invest 2021;44:2227-2234. https://doi.org/10.1007/s40618-021-01528-1
- Giannetta E, Guarnotta V, Rota F, et al. A rare rarity: neuroendocrine tumor of the esophagus. Crit Rev Oncol Hematol 2019;137:92-107. https://doi.org/10.1016/j.critrevonc.2019.02.012
- Wu IC, Chu YY, Wang YK, et al. Clinicopathological features and outcome of esophageal neuroendocrine tumor: a retrospective multicenter survey by the digestive endoscopy society of Taiwan. J Formos Med Assoc 2021;120:508-514. https://doi.org/10.1016/j.jfma.2020.06.024
- Chun HJ, Park SJ, Lim YJ, Song SY. Gastrointestinal cancer: a comprehensive guide to diagnosis and management. Singapore: Springer, 2023. p.437-446.
- Feola T, Puliani G, Sesti F, et al. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study. J Endocrinol Invest 2022;45:849-857. https://doi.org/10.1007/s40618-021-01715-0
- Barrea L, Muscogiuri G, Modica R, et al. Cardio-metabolic indices and metabolic syndrome as predictors of clinical severity of gastroenteropancreatic neuroendocrine tumors. Front Endocrinol (Lausanne) 2021;12:649496. https://doi.org/10.3389/fendo.2021.649496
- Scherubl H, Jensen RT, Cadiot G, Stolzel U, Kloppel G. Management of early gastrointestinal neuroendocrine neoplasms. World J Gastrointest Endosc 2011;3:133-139. https://doi.org/10.4253/wjge.v3.i7.133
- Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76:182-188. https://doi.org/10.1111/his.13975
- Nam K, Nam SY, Park JC, et al. Factors associated with gastric and duodenal neuroendocrine tumors: a multicenter case-control study. Dig Liver Dis 2024. https://doi.org/10.1016/j.dld.2024.01.210